• 제목/요약/키워드: Glottis cancer

검색결과 22건 처리시간 0.018초

성문암 세기변조방사선치료에서 두 가지 열가소성 마스크에 대한 환자위치잡이 오차 평가 (Comparison of Setup Deviations for Two Thermoplastic Immobilization Masks in Glottis Cancer)

  • 정재홍
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제40권1호
    • /
    • pp.63-70
    • /
    • 2017
  • 본 연구는 세기변조방사선 치료기술을 이용한 성문암 환자에게 사용되는 두 가지 상이한 열가소성 고정기구 마스크로 인한 환자위치잡이 오차를 비교 평가하고 자 하였다. 치료가 종료된 총 16명의 성문암 환자를 두 그룹으로 나누었고(기존마스크 vs. 변형마스크), 평균, 3D오차, 시스템과 랜덤오차를 구하여 환자위치잡이 오차를 비교하였다. 또한, 치료계획종양체적(PTV)에 대한 여백(margin)을 분석하였다. 3D오차에 대하여 기존 그룹은 $5.2{\pm}1.3mm$고, 변형그룹은 $5.9{\pm}0.7mm$로써, 변형마스크가 변형보다 13.6% 높았다. 시스템오차는 기존그룹(변형그룹)에서 좌표 x, y, z방향은 각각 1.7 mm (1.1 mm), 1.0 mm (1.8 mm), 1.5 mm (2.0 mm)였고, 회전각(roll angle)은 $0.8^{\circ}$ ($0.8^{\circ}$)였다. 랜덤오차는 변형그룹이 기존그룹에 비하여 좌표 x, y, z방향으로 10.9%, 1.7%, 23.1%로 낮았으나, 회전각은 12.4% 높았다. PTV여백에서 변형그룹은 좌표 x방향에 대하여 기존그룹에 비하여 31.8% 낮았으나, 반대로 좌표 y와 z방향에서는 기존그룹보다 각각 52.6%와 21.6%로 높았다. 성문암 세기변조방사선치료에서 변형된 마스크 사용은 고정기구의 변형으로 인한 환자위치잡이 오차는 수치적으로는 영향을 줄 수 있지만, 다양한 관점에서 고정기구 마스크에 대한 연구가 임상적인 측면에서 연구가 필요할 것으로 사료된다.

Epidemiological Study of Laryngeal Carcinoma in Western Nepal

  • Koirala, Krishna
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권15호
    • /
    • pp.6541-6544
    • /
    • 2015
  • Background: Laryngeal malignancy is a common malignancy of the head and neck region. Affected patients usually present with features that are characteristic of certain subsites. The larynx is oncologically divided into three: supraglottis, glottis and subglottis. Studies from Western countries have shown that the glottis is the commonest subsite to harbour laryngeal malignancy. However, the supraglottis has been reported to be the commonest subsite in developing countries, including examples in the Indian subcontinent. To our knowledge, no study has been carried out in western Nepal about the epidemiology of laryngeal cancer to date. The purpose of this study was to analyse the epidemiology of laryngeal cancer in relation to its risk factors, age distribution,and preferred subsites and to see if there is any recent change in the subsite wise distribution of laryngeal malignancy in western Nepal. Materials and Methods: Patients of all ages and both sexes with suspected laryngeal malignancy were enrolled in the initial study. Detailed history taking and clinical examination was performed to find out the involved subsite in relation to the clinical features. Direct laryngoscopy was performed to further confirm the subsite and to take biopsy from the growth under general anesthesia. After confirmation of malignancy from the biopsy report, patients were finally included in the study. Data were analysed and observations were made to find out the distribution of laryngeal malignancy in different subsites. Results: The supraglottic larynx was the commonest subsite to harbor laryngeal malignancy. Smoking and alcohol were found to be the common risk factors. The mean age of the patients was in their sixties. Conclusions: Laryngeal malignancy is common in elderly individuals. Supraglottic laryngeal malignancy is the commonest laryngeal malignancy in people who smoke and drink alcohol in Nepal. Avoidance of alcohol use and smoking will be a milestone to reduce the incidence of laryngeal cancers and associated mortality.

성대암에서 $CO_2$ 레이저를 이용한 경구강절제술 (Transoral $CO_2$ Laser Microsurgery for Glottic Carcinoma)

  • 정필상;문태현
    • 대한기관식도과학회지
    • /
    • 제16권1호
    • /
    • pp.20-26
    • /
    • 2010
  • Transoral $CO_2$ Laser Microsurgery of glottic Carcinoma is replacing external approaches. The qualify of life after surgery for laryngeal cancer may be as important as complete resection of the tumor for patient. Transoral $CO_2$ laser cordectomy for the management of early laryngeal cancer has advantages with regard to oncological results, preservation of laryngeal functions, morbidity and cost in comparison to those of open surgery or radiation therapy. Moreover, transoral laser surgery can be a useful choice as a salvage surgery in radiation therapy failed early glottic cancer. A classification of laryngeal endoscopic cordectomies which included eight different types was described by the European laryngological Society in 2000. We will also introduce type VI which was newly proposed recently.

  • PDF

오차 원발성 중복암 1례 (A Case of Fifth Primary Cancer)

  • 최은창;김영호;윤정선
    • 대한두경부종양학회지
    • /
    • 제13권1호
    • /
    • pp.58-61
    • /
    • 1997
  • Multiple primary cancer is defined as the discrete primary cancers in an individual originating in different sites or tissues. Billroth, in 1869, first reported the occurrence of different primary malignant cancers in the same patient. Because early diagnosis and treatment are key to good survival and cure rates, clinicians should be more aware of the possibility of multiple primary cancers in an individual patient with malignant tumor. The authors recently experienced a case of fifth primary cancer, their sites of origin were lung, glottis, lymph node, supraglottis, common bile duct. We report this case with a brief review of literatures.

  • PDF

진행된 성문상부암의 발생부위별 임상적 특성에 관한 연구 (Clinical Characteristics of Advanced Supraglottic Cancer by Subsites)

  • 정광윤;최종욱;이종수
    • 대한두경부종양학회지
    • /
    • 제9권2호
    • /
    • pp.193-199
    • /
    • 1993
  • The prognosis of supraglottic cancer is worse than that of glottic cancer. Supraglottic cancers by subsites have different microenvironment of cancer cells, locoregional spread patterns. Therefore we presume that high therapeutic efficacy, while preserving the organ, can be obtained when supraglottic cancer is treated effectively according to its biological behaviors. For the purpose of determination of clinical characteristics and causes of treatment failures by subsites of supraglottis, the authors analyzed 24 cases(stage III 14 cases, stage IV 10 cases) of supraglottic cancer which were managed mainly by surgery in our institute. The results were as follows; 1) The suprahyoid group had worse pathologic grades, more frequent spread to hypopharynx, more freguent recurrence at primary site, and better three-year survival rate than the infrahyoid group. 2) The infrahyoid group had more frequent spread to glottis, understaging, recurrence at cervical nodes than the suprahyoid group. 3) There was no differences in nodal metastasis by sub sites. These results suggest that the suprahyoid group may have more aggressive spread pattern but better prognosis than the infrahyoid group.

  • PDF

Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution

  • Lee, Jeong Won;Lee, Jeong Eun;Park, Junhee;Sohn, Jin Ho;Ahn, Dongbin
    • Radiation Oncology Journal
    • /
    • 제37권2호
    • /
    • pp.82-90
    • /
    • 2019
  • Purpose: To evaluate the results of hypofractionated radiotherapy (HFX) for early glottic cancer. Materials and Methods: Eighty-five patients with cT1-2N0M0 squamous cell carcinoma of the glottis who had undergone HFX, performed using intensity-modulated radiotherapy (IMRT, n = 66) and three-dimensional conformal radiotherapy (3D CRT, n = 19) were analyzed. For all patients, radiotherapy was administered at 60.75 Gy in 27 fractions. Forty-three patients received a simultaneous integrated boost (SIB) of 2.3-2.5 Gy per tumor fraction. Results: The median follow-up duration was 29.9 months (range, 5.5 to 76.5 months). All patients achieved complete remission at a median of 50 days after the end of radiotherapy (range, 14 to 206 days). The 5-year rates for locoregional recurrence-free survival was 88.1%, and the 5-year overall survival rate was 86.2%. T2 stage was a prognostic factor for locoregional recurrence-free survival after radiotherapy (p = 0.002). SIB for the tumor did not affect disease control and survival (p = 0.191 and p = 0.387, respectively). No patients experienced acute or chronic toxicities of ≥grade 3. IMRT significantly decreased the dose administered to the carotid artery as opposed to 3D CRT (V35, p < 0.001; V50, p < 0.001). Conclusions: Patients treated with HFX achieved acceptable locoregional disease control rates and overall survival rates compared with previous HFX studies. A fraction size of 2.25 Gy provided good disease control regardless of SIB administration.

후두 및 하인두 편평세포암종의 경부 잠재전이율 (Occult Neck Metastasis Rate of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma)

  • 최은창;김동영;고윤우;홍정표;이세영;홍원표
    • 대한두경부종양학회지
    • /
    • 제15권1호
    • /
    • pp.18-21
    • /
    • 1999
  • Background and Objectives: Occult neck metastasis rate of laryngeal and hypopharyngeal cancer varies widely depending upon authors. Materials and Methods: Sixty four cases, previously untreated, of N0 laryngeal and hypopharyngeal squamous cell carcinoma patients who underwent surgery as an initial treatment from 1992 to 1997 were evaluated. All had unilateral or bilateral elective neck dissection at the time of surgery for the primary. Occult neck metastasis rate was evaluated with pathologic examination of neck dissection specimen. Results: Occult neck metastasis rate by primary site was as follows. Supraglottis ipsilateral 32%(8/25) contralateral 15%(3/20), glottis ipsilateral 17%(5/30), contralateral 0%(0/22), hypopharynx ipsilateral 78%(7/9), contralateral 25%(2/8). Conclusion: Supraglottic and hypopharyngeal cancer may need elective neck treatment bilaterally. Occult neck metastasis of glottic cancer to opposite site was minimal.

  • PDF

방사선 치료 후 중심경부림프절에서 재발한 조기 성문암 1예 (A Case of Recurrent Central Neck Lymph Nodes after Radiation Therapy for Early Glottic Cancer)

  • 박의현;주영호;황재웅;박상헌;백승국
    • 대한두경부종양학회지
    • /
    • 제29권2호
    • /
    • pp.58-61
    • /
    • 2013
  • Early glottic cancer can be effectively treated with surgery or radiotherapy showing the comparable treatment results. Since radiation therapy may be better in terms of voice preservation, it tends to be preferred in early glottic cancer. Most common recurrence site is glottis after radiation therapy and complete remission of glottic primary site followed by local recurrence limited to neck is very rare. The authors are reporting a patient with regional recurrence of central neck lymph nodes after radiation therapy for T1a glottic cancer.

병기 T1 성문암의 방사선치료 (Radiation Therapy in T1 Glottic Cancer)

  • 정은지;이상욱;이창걸;김귀언;김광문;홍원표
    • 대한두경부종양학회지
    • /
    • 제12권1호
    • /
    • pp.26-31
    • /
    • 1996
  • Radiation therapy in T1 glottic cancer offers an excellent cure rate with preservation of voice. From 1983 to 1992 eighty nine patients with TNM staged T1N0M0 invasive squamous cell carcinoma of the glottis were treated at the Dept. of Radiation Oncology, Yonsei Cancer Center, Yonsei University. There were 84 men and 5 women with median age of 59 years. All patients were treated either with Co-60 teletherapy unit or 4MV linear accelerator with an median dose of 6400 cGy(6000-7000 cGy), 200 cGy per day, 5 days in a week. Fourteen local failures have been observed and the median time to local recurrence was 17 months. There were no nodal failure without local recurrence or distant metastases. The 5 year local control rate was 84.3%. The 5 year actuarial surivival rate and the 5 year disease free survival rate were 89.2%, 87.5%, respectively. The 5 year actuarial survival rate and the 5 year disease free survival rate of the nineteen patients with anterior commissure involvement were 77.8% and 74.5% which were lower than those of seventy patients without anterior commissure involvement(91.6%, 90.6%)(p < 0.05). Among the several influencing factors, anterior commissure involvement was the significant prognostic foctor. Final local control rate, taking into account the salvage surgery, was 89.9% at 5 years.

  • PDF